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ABSTRACT
Adaptation to fasting involves both Glucocorti-
coid Receptor (GR) and Peroxisome Proliferator-
Activated Receptor  (PPAR) activation. Given
both receptors can physically interact we investi-
gated the possibility of a genome-wide cross-talk
between activated GR and PPAR , using ChIP-
and RNA-seq in primary hepatocytes. Our data re-
veal extensive chromatin co-localization of both fac-
tors with cooperative induction of genes control-
ling lipid/glucose metabolism. Key GR/PPAR co-
controlled genes switched from transcriptional an-
tagonism to cooperativity when moving from short
to prolonged hepatocyte fasting, a phenomenon co-
inciding with gene promoter recruitment of phos-
phorylated AMP-activated protein kinase (AMPK) and
blocked by its pharmacological inhibition. In vitro
interaction studies support trimeric complex forma-
tion between GR, PPAR and phospho-AMPK. Long-
term fasting in mice showed enhanced phospho-
rylation of liver AMPK and GR Ser211. Phospho-
AMPK chromatin recruitment at liver target genes,
observed upon prolonged fasting in mice, is damp-
ened by refeeding. Taken together, our results iden-
tify phospho-AMPK as a molecular switch able to
cooperate with nuclear receptors at the chromatin
level and reveal a novel adaptation mechanism to
prolonged fasting.
INTRODUCTION
Peroxisome Proliferator-Activated Receptor  (PPAR) is
a lipid sensing nuclear receptor activated by fatty acids (FA)
and other lipid derivatives. High levels of PPAR coincide
with the FA oxidative capacity of a tissue and are typically
found in heart, liver and kidney (1). Additionally, its expres-
sion levels and activity significantly increase during fasting,
which allows for the maintenance of physiological glucose
levels and a switch toward FA oxidation and production of
ketone bodies by the liver (2,3). The classic transactivation
mechanism of PPAR involves hetero-dimerization with
the Retinoid X Receptor and interaction with direct-repeat
1 type response elements. This mechanism is involved in the
transcriptional control of a broad range of lipid metabolic
genes (4). Besides its metabolic function, PPAR also ex-
erts an anti-inflammatory activity by inhibiting NF-B and
AP-1 via a mechanism termed transrepression (5). Our re-
cent data on the transrepression activity of PPAR link its
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anti-inflammatory activity to the prevention of progression
of chronic inflammation to fibrosis in the liver (6).
The glucocorticoid receptor (GR) is a nuclear recep-
tor activated by steroidal stress hormones, glucocorticoids.
Mechanistically, GR can signal as a homo-dimer recogniz-
ing palindromic glucocorticoid response elements (GREs)
or via tethering of the GR monomer to other transcription
factors, including AP-1 and NF-B (7) or to GRE half sites
(8,9). Ubiquitously expressed GR is predominantly studied
for its potent anti-inflammatory action mechanisms (10).
Nevertheless, endogenous glucocorticoids’ (GCs) role ex-
tends beyond inflammation control given their important
role in restoring energy homeostasis during nutrient depri-
vation. During prolonged fasting, GCs stimulate lipolysis
and a flux of free FAs to the liver. This physiological re-
sponse provides substrates for gluconeogenesis (11) and, to-
gether with a direct regulation of gluconeogenic gene ex-
pression by the GR, ensures sustained glucose levels during
fasting. Cooperative molecular control mechanisms under
a state of catabolic fasting are less well characterized, how-
ever.
AMP-activated protein kinase (AMPK) is a ubiquitously
expressed kinase involved in cellular energy homeostasis.
The canonical AMPK activation mechanism involves a re-
sponse to increased cellular AMP levels, which may occur
during states of nutrient deprivation, leading to increased
AMPK -subunit activation loop Thr172 phosphorylation.
Activated AMPK switches off anabolic processes and pro-
motes energy-generating catabolic pathways (12). Further-
more, pharmacological AMPK activation was shown to re-
verse GC-induced steatosis in non-fasted rat liver and to
suppress GC-induced elevation of blood glucose and hep-
atic glycogen (13). Similarly to PPAR, AMPK activation
stimulates the uptake and oxidation of FAs, although the
mechanistic details of their relationship remain to be elu-
cidated. In a previous study describing an additive anti-
inflammatory effect of PPAR and GR, we demonstrated
that both nuclear receptors can physically interact (14).
Since both GR and PPAR are known to be active under
fasting conditions and involved in the adaptation of an or-
ganism to nutrient deficiency, we therefore wondered if and
how they could cross-talk in this context, and approached
the question at a genome-wide level starting with a primary
(murine) hepatocyte model. Via ChIP- and RNA-seq we
mapped hepatic cistromes of GR and PPAR and coupled
them to the transcriptional response observed upon single
and combined agonist treatment. We show that both tran-
scription factors mainly co-localize in the vicinity of lipid
catabolism genes and cooperatively induce their expression
when co-activated. Bymimicking fed-to-fast and fast-to-fed
transitions, we show a strong dependence of the cooperative
response on hepatocyte nutritional status and demonstrate
that under fasting conditions activatedAMPK is directly re-
cruited to promoters of the cooperatively induced genes in
response to a combinedGR/PPAR activation. AMPKac-
tivity is also required for the cooperative response as shown
using a pharmacological AMPK inhibitor. GST-pull down
assays demonstrate that recombinant activated AMPK, re-
combinant PPAR and in vitro translated GR can phys-
ically associate, which might be indicative of a trimeric in-
teraction model at key target gene promoters.
As a continued fasting coincides with an enhanced re-
cruitment of phospho-AMPK at target gene promoters
in liver––an effect that was partially inhibited following a
short refeeding––we show that in vitro findings were also
confirmed in vivo. Upon prolonged fasting, not only en-
hanced levels of phospho-AMPK were detected, but also
enhanced levels of GR phosphorylated at Ser211. Finally,
besides shedding light on the transcriptional coordination
of glucose and FA metabolism by nuclear receptors, using
metabolomics we show that a dual activation of GR and
PPAR completely counteracts the accumulation of pri-
mary hepatocyte intracellular FAs observed upon treatment
with GR-ligand alone, demonstrating an extension of the
GR/PPAR cross-talk beyond gene pattern changes.
MATERIALS AND METHODS
Primary hepatocyte isolation
All experimental protocols were approved by the Lille Pas-
teur Institute ethical committee and carried out in agree-
ment with EuropeanUnion (EECn◦07430) and French eth-
ical guidelines. Primary hepatocytes were isolated from 10–
12 week old PPAR-WT or PPAR-KO C57BL/6 mice by
collagenase perfusion (15). The procedure was modified by
excluding insulin andDex supplementation in theWilliam’s
medium (Sigma, W1878). Additional culture details are
provided in the Supplementary Materials and Methods.
ChIP
Each replicate was obtained by pooling cells from three an-
imals. Stimulation was done for 1 h with: solvents (0.01%
DMSO, 0.01% EtOH), 1 M of Dexamethasone (Dex)
(Sigma, D4902-25MG), 0.5 Mof GW7647 (GW) (Sigma,
G6793-5MG) or a combination of Dex and GW. Single lig-
and treatments were additionally supplemented with the
missing solvents. Proteins were cross-linked to DNA for
10 min using 1% formaldehyde and the cross-linking reac-
tion was stopped by adding glycine to a final concentra-
tion of 0.125 mM. Cells were scraped in ice-cold phosphate
buffered saline (PBS), washed 2x and snap frozen in liquid
nitrogen before chromatin preparation and immunoprecip-
itation (IP). Detailed ChIP protocol is provided in the Sup-
plementaryMaterials andMethods. For ChIP-seq, samples
from 6 independent immunoprecipitations, obtained using
2 biological replicates were pooled, concentrated by dry-
ing and additionally sonicated (16) (20 cycles, 30 s on/30 s
off, high intensity). Libraries were prepared using Illumina
TruSeq Kit and subjected to a single-end 50 bp sequencing
on the Illumina HiSeq 2000.
RNA-isolation
For RNA-seq and qPCR experiments primary hepatocyte
cells were processed as described above. Stimulation was
done for 19 h (RNA-seq and qPCR) or for 2, 4 and 6 h
(time-kinetics qPCR). Each replicate was obtained by pool-
ing cells from 3–4 mice and 3 independent replicates were
used for RNA-seq and qPCR experiments. RNA was iso-
lated with the RNeasy purification kit (Qiagen, cat. 74106)
according to the user’s manual. The RNA-seq library was
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prepared using Illumina Tru-seq kit with poly-A selection
and subjected to a single-end 50 bp sequencing on the Il-
lumina GAII. For qPCR, cDNA was synthesized with a
PrimeScript kit (Takara, cat. 6110B).
Metabolomics
For the metabolomics experiment, primary hepatocytes
were isolated and stimulated as for ChIP experiments. Each
sample was replicated independently six times. After 19 h
of stimulation, cells were detached by 5 min trypsiniza-
tion, resuspended in Dulbecco’s modified Eagle’s medium
(DMEM) (Gibco, 41966-052) supplemented with 10% fetal
bovine serum (FBS) and washed with PBS. Cell pellets were
snap frozen in N2 and processed further by Metabolon,
Inc. (mView platform). Details of the sample processing are
available upon request and additional information on the
analysis is provided in the Supplementary Materials and
Methods.
ChIP-seq analysis
Reads were mapped to the mm9 genome using Bowtie2 ver-
sion 2.0.5. Peaks were called with MACS version 1.4.2 (17)
(P-value< 10−8) and filtered based on fold enrichment (>6x
above input). Motif analysis was performed with meme-
chip (18), homer (19) and FIMO (20). Distances between
peaks and Transcription Start Sites’ (TSS’s) of differentially
expressed genes were calculated with bedtools (21). More
details are provided in the Supplementary Materials and
Methods.
RNA-seq analysis
Reads were mapped to the mm9 genome using tophat (22)
(version 2.0.7) supplied with ensembl annotation (param-
eters: –G, –no coverage search). Transcriptomes were as-
sembled with cufflinks (23) (version 2.0.2, parameters: -
q, -u, -b) and combined into a single assembly, including
mm9 ensembl annotation with cuffmerge (parameters: -g,
-s). The joint assembly was used as a reference for differ-
ential expression testing using cuffdiff (23) (parameters: -q,
-N, -u, -b). Gene level differential expression analysis was
performed with the aid of the R package ‘cummeRbund’
(24) by applying the following contrasts ( = 0.05): NI
(non-induced, i.e. solvent only) versus Dex, NI versus GW,
NI versus DexGW, Dex versus DexGW and GW versus
DexGW. Differentially expressed genes were combined into
a single list (excluding non-protein coding genes), FPKM
expression values were scaled across conditions (Z-score)
and genes were re-ordered using a hierarchical clustering
based on Euclidean distances. Data were partitioned into
clusters by cutting the clustering tree at the height of 2.3,
which resulted in 10 clusters. The result was visualized (Sup-
plementary Figure S4) and expression patterns were exam-
ined to identify the main patterns of interaction between
the ligands and guide significance testing for co-regulated
genes. Two smallest clusters with 1 and 3 genes, respectively,
where omitted from the visualization and peak/gene on-
tology (GO) enrichment analysis. The following filter was
used to extract cooperatively induced genes: up-regulation
by DexGW as compared to NI and significantly higher ex-
pression in DexGW as compared to Dex and GW alone.
GO-analysis of gene clusters was performed using ‘goseq’
R-package (25). All enrichment p-values in GO analysis
were corrected for multiple testing using the Benjamini–
Hochberg method.
Accession numbers
ChIP-seq and RNA-seq data have been uploaded to the
NCBI-SRA repository and are available under SRP058743
accession.
qPCR and ChIP-qPCR
qPCR’s were performed using Light Cycler 480 SYBR
Green I Master Mix (Roche, cat. 04887352001) (primer list
provided in the Supplementary Materials and Methods).
qPCR data were normalized and quantified relative to the
two most stable reference genes with qBase (26) and ex-
pressed relative to the control (NI) condition. Statistical
analysis was performed using R (R Core Team (2014) R:
A Language and Environment for Statistical Computing)
and GraphPad Prism (see details in figure legends).
MAPPIT
MAPPIT was performed as described earlier (27), with its
principle depicted in Figure 6C. Briefly, Hek293T cells were
seeded at the density of 10 000 cells/well on a 96well plate in
DMEM (Gibco, 41966-052) supplemented with 10% FBS.
Next day 25 ng of bait, 50 ng of prey and 5 ng of the STAT3-
dependent pXP2d2-rPAPI-luciferase reporter vector were
transfected using a standard calcium phosphate transfec-
tion method. After 24 h, the reporter was stimulated with
leptin (100 ng/ml) and reporter activity was measured 24
h after leptin stimulation using the Luciferase Assay Sys-
tem kit (Promega) on anEnvision luminescence plate reader
(Perkin–Elmer). Signals for each interaction are presented
as fold induction of the luciferase signal of leptin-stimulated
versus unstimulated samples. The fold induction is a mea-
sure of the interaction strength.
The pXP2d2-rPAPI-luciferase reporter vector (28), the
plasmids encoding the full size GR bait (pCLG-GR; (29)
and the irrelevant bait containing a fusion with E. coli
DHFR (pCLG-eDHFR; (30)) and the empty control prey
plasmid encoding unfused gp130 (pMG1) have been de-
scribed previously (27). The PRKAG2 and PRKAG3 prey
plasmids (pMG1-PRKAG2 and pMG1-PRKAG3, respec-
tively) were generated by Gateway (Thermo Fisher Scien-
tific) recombinatorial cloning of the full size PRKAG2 and
PRKAG3 entry clones from the human ORFeome version
8.1 collection (31) into the pMG1 vector as described (27).
The PPAR bait plasmid (pCLG-PPAR) was generated
by substituting the GR encoding sequence of the pCLG-
GR vector with the full size coding sequence of PPAR.
GST-pull down
Anti-GST beads Glutathione Sepharose 4B beads (GE
Healthcare Life Sciences cat. 17-0756-05) were incubated
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with GST-PPAR or GST-5HT7 (negative control) in
NETN-buffer (20 mM Tris-HCl pH8, 100 mM NaCl, 6
mM MgCl2, 1 mM EDTA, 0.5% NP40, 1% DTT, Com-
plete Protease Inhibitor Cocktail (Roche cat. 11836145001)
and protein phosphatase inhibitors (1 mMNaF and 1 mM
NaVO3)). Beads were first blocked with NETN-buffer +
2% nonfat milk powder for 1 h. Next, GST-protein binding
beads were washed 3x in NETN-buffer and re-suspended
in 280 l modified NETN-buffer (20 mM Tris-HCl pH8,
8% glycerol, 300 mM NaCl, 6 mM MgCl2, 1 mM EDTA,
0.05% NP40, 1% DTT, Complete Protease Inhibitor Cock-
tail (Roche cat. 11836145001) and protein phosphatase in-
hibitors (1 mM NaF and 1 mM NaVO3)). Activated and
His-tagged AMPK complex 121 (2.6 g/sample) to-
gether with in vitro transcribed and translated proteins
(TnT Quick Coupled Transcription/Translation System,
Promega, cat. L1170) were added to bead solution at a
volume as indicated in the Figure, together with 0.5 M
of GW7647 and 1 M of Dex. Binding reaction was car-
ried out at 4◦C with rotation overnight. Following 3 wash
steps withmodifiedNETN-buffer, proteins were elutedwith
Laemmli buffer, boiled for 3 min and loaded on the gel
for Western Blot analysis. Active AMPK was detected with
anti-phospho-Thr172 AMPK1/2 (Santa-Cruz, sc-33524),
GR with anti-GR (H-300, Santa Cruz, sc-8992) and GST-
PPAR and GST-5HT7 ctrl (kind gift of Dr K. Van Crae-
nenbroeck, UGent) with anti-GST (Abcam, cat ab9085).
Recombinant bacterially expressed AMPK (11 1) was
activated with recombinant bacterially expressed LKB1-
MO25-STRAD complex (Bultot et al. 2012), both kindly
provided by Dietbert Neumann (Institute of Cell Biology,
ETH Zurich, CH).
In vivo analysis
C57BL/6J male mice of 8 weeks old were obtained from
Charles River. The specific treatment set-up has been spec-
ified in the legend of Figure 7. In panel A, 10 male mice
underwent a 16 h starvation regimen. Groups were subse-
quently split in two, with 5 mice allowed a refeeding (‘fast-
refed’) whilst the other 5 mice stayed fasting (‘fast-fast’).
Thirty minutes later, mice were sacrificed; both sera and liv-
ers were collected for analysis. In panel C, 5 mice/group
were fasted for either 3 h or 16 h, after which either placebo
or a combination of water-soluble Dex (2 mg/kg) and GW
(2 mg/kg) was given i.p. Four hours later, mice were sacri-
ficed and the liver was analyzed for mRNA expression via
qPCR analysis. Experiments were approved by the animal
ethical committee of the faculty of medicine at the Univer-
sity of Ghent (code dossier 14/84).
RESULTS
Shared binding sites of GR and PPAR concur with an en-
richment of GRE and PPRE motifs
For an unbiased insight into the genomic cross-talk between
GR and PPAR, we performed a ChIP-seq experiment us-
ing primary murine hepatocytes treated for 1 h with sol-
vents (non-induced – NI), dexamethasone (Dex), GW7647
(GW) and a combination of Dex and GW. In total, we de-
tected 15 619 and 3541 genomic binding sites for GR and
GR PPARα
Co-Bound
PPARα
unique
GRα
unique
A C
GR
PPARα13630
1989 1552
B D
Figure 1. Glucocorticoid receptor (GR) and peroxisome proliferator-
activated receptor  (PPAR) binding sites (primary murine hepatocytes
ChIP-seq) co-occupancy, motif enrichment and GO annotation. (A) The
heatmap shows normalized tag densities (represented by the color scale)
for GR and PPAR on unique and co-bound peaks upon combined lig-
and treatment. (B) Venn diagram representation of binding sites overlap.
(C) The functional annotation of co-bound peaks using GO terms asso-
ciated with the nearest genes. (D) Fraction of unique and co-bound peaks
with de novo GRE or PPRE motifs as identified by MEME-ChIP/FIMO
(P-value < 10−4) (see also Supplementary Figure S1).
PPAR, respectively. No major rearrangement of the bind-
ing sites was observed when comparing single and com-
bined ligand stimulations (Supplementary Figure S1A and
B), hence we intersected complete sets of GR and PPAR
peaks to test the extent of the peak overlap. Using 200 bp
as a maximum summit-to-summit distance between peaks
to consider them as overlapping, 1989 peaks were identi-
fied passing this threshold. This number represents a sig-
nificant fraction of all PPAR peaks (56%), and––given
the higher total number of GR binding sites––a relatively
smaller subset of GR peaks (13%) (Figure 1A and B). Anal-
ysis of pathway enrichment terms among genes in the vicin-
ity of overlapping peaks showed a consistent enrichment
of terms related to lipid metabolism, suggesting a possi-
ble preferential co-regulation of those genes by GR and
PPAR (Figure 1C). To gain mechanistic insight, we in-
vestigated which motifs are enriched among overlapping
peaks as compared to peaks uniquely bound by each recep-
tor (Supplementary Figure S1C–F). Compared to uniquely
bound GR peaks, overlapping ones were mainly enriched
for PPRE and PPRE-like motifs (Supplementary Figure
S1F). Conversely, when uniquely bound PPAR peaks were
used as a background, co-bound peaks were predominantly
enriched for GRE and GRE-like motifs, such as PRE and
AR/GR-half-sites, together with C/EBP and HNF6 (Sup-
plementary Figure S1E). This result was further confirmed
by a targeted motif scan using de novo generated GRE and
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Figure 2. Binding of GR and PPAR to co-bound peaks with PPRE motifs in primary hepatocytes from PPAR-WT and -KO mice. (A) ChIP-seq
profiles of GR and PPAR at the Pdk4 upstream enhancer. (B) ChIP-qPCR on the Pdk4 enhancer and a model illustrating co-occupancy via a tethering
mechanism. (C) ChIP-seq profiles of GR and PPAR within the Angptl4 intron. (D) ChIP-qPCR on the Angptl4 intron and a model illustrating co-
occupancy via independent binding. The pink rectangles on the ChIP-seq tracks (A and C) mark peaks, which were tested via ChIP-qPCR and bar plots
show enrichment relative to non-induced (WT) sample. Statistical analysis (one-way-ANOVA with a Tukey post-hoc test, n = 3) is shown for selected
comparisons (** and *** denote P-values< 0.01 and< 0.001, respectively). (E) The scatter plot shows ChIP-seq tag counts for GR and PPAR co-bound
sites with GRE in NI and Dex conditions. NI, non-induced (solvent only), Dex, Dexamethasone.
PPRE motifs. Thus, GR and PPAR could interact with
close co-occurring motifs within shared binding sites. A
higher frequency of PPREs as compared to GREs in over-
lapping peaks (Figure 1D) also suggested a possibility for
indirect GR recruitment via tethering to PPAR.
Co-recruitment of GR to shared PPRE-containing binding
regions shows site-specific dependency on PPAR
In order to test whether GR recruitment to select co-bound
regionswith PPREmotifs is dependent on PPAR, we com-
pared primary hepatocytes fromPPAR-WT and -KOmice
(32). When examining PPRE-containing co-bound regions
upstream of Pdk4 (Figure 2A) and in the gene body of
Angtpl4 (Figure 2C) via ChIP analysis, we found that for
bothmodel genes the PPAR signal was lost in PPAR-KO
hepatocytes, as expected (Figure 2B andD, left panels). This
was also confirmed for six additional, PPRE-containing co-
bound regions tested (Supplementary Figure S2). Interest-
ingly, the absence of PPAR also influenced GR recruit-
ment to a subset of the shared binding sites tested. The
intronic site within Angptl4 and the Pdk4 enhancer repre-
sent two extreme cases where GR-binding is either com-
pletely lost (Figure 2B, right panel) or unaffected (Figure
2D, right panel) in PPAR-KO cells, respectively. The GR
signal was also significantly reduced in the presence of both
ligands when comparing WT with PPAR-KO at sites near
Agpat3 and Plin5. Similar, trends were observed for peaks
near Eci2, Acad11 and Cbfa2t3 but effects did not meet a
significance threshold (Supplementary Figure S2).
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To extend the analysis and interrogate whether PPAR
activation can influence GRE-bound GR, we made use of
the fact that DNA binding of GR, in contrast to PPAR,
is strongly ligand dependent. Therefore, one would expect
that in the case of tethering, PPAR occupancy in co-bound
regions harboring a GRE should increase following Dex
stimulation.Our analysis shows thatGRoccupancy at these
sites indeed clearly increases in the presence of Dex. How-
ever, PPAR occupancy remains largely unaffected (Figure
2E), arguing against a tethering of PPAR to GRE-bound
GR. As an additional control, by using EMSA analysis we
excluded that independent binding could alternatively be
explained by direct recruitment of GR to PPRE motifs and
vice versa – PPAR to GRE (Supplementary Figure S3). In
summary, we conclude that while the recruitment of GR via
either tethering to PPAR or else assisted by a pioneering
role for PPAR is possible (as shown for Pdk4, Plin5 and
Agpat3), their frequent close co-localization can also rep-
resent independent binding events (as shown for Angptl4
and Dpep2) – facilitated either directly via co-occurring
PPRE andGREmotifs or else via an interaction with other
transcription factors or non-canonical/degenerate motifs
present in co-bound regions.
Co-activation of GR and PPAR triggers cooperative activa-
tion of lipid metabolic pathways and counteracts Dex-induced
hepatic FA accumulation
Frequent co-localization of GR and PPAR on the chro-
matin prompted us to further investigate the transcriptional
cross-talk. To this end we performed RNA-seq analysis in
primary murine hepatocytes upon single and combined lig-
and stimulation. Differentially expressed genes were identi-
fied for a set of pairwise contrasts (NI versus Dex, NI ver-
sus GW, NI versus DexGW, GW versus DexGW and Dex
versus DexGW) (Supplementary Figure S4), combined into
a single list and next fed into a hierarchical clustering al-
gorithm to identify predominant expression patterns across
treatments (Supplementary Figure S5). With this approach
we could partition the data into eight main clusters (Sup-
plementary Figure S5), which were further analyzed for en-
richment of GO terms (Supplementary Table S1) and pres-
ence of nearby GR and PPAR binding sites (Supplemen-
tary Figure S5). For all gene clusters, nearbyGRpeaks were
more common than PPAR peaks, which is not surpris-
ing given their larger total number and more genes differ-
entially expressed in response to Dex as compared to GW
(Supplementary Figure S4). However, two clusters (Supple-
mentary Figure S5 clusters 1 and 2) stood out as (i) coop-
eratively activated, (ii) highly enriched with peaks for both
receptors and (iii) enriched for similar GO terms related
to lipid metabolism (Supplementary Table S1). To narrow
this list down, we retrieved differentially expressed genes for
which expression upon combined stimulation was signifi-
cantly higher than for each ligand alone (False Discovery
Rate= 5%), which yielded 93 high confidence, cooperatively
induced genes (Figure 3A). Repeating the functional anno-
tation on this smaller gene set confirmed strong enrichment
of terms related to lipid metabolism (Figure 3B), while peak
enrichment analysis established that these are potentially di-
rect targets, i.e. we could detect binding sites for GR and
PPAR within 20 kb from TSSs for close to 80% of those
genes (Figure 3C). Example genes in this group encode
proteins involved in the release of FA from adipose tissue
(Angptl4) (33), FA transport (Fabp4, Cpt1a, Cpt2) (34–36),
FA activation (Acot1, Acot2) (37,38), triglyceride hydroly-
sis (Pnpla2/Atgl) (39) and ketone body synthesis (Hmgcs2)
(40) as well as enzymes involved in FA -oxidation such as
Acox1, Hadha, Hadhb, Ehhadh, Eci2, Acadl and Acadvl.
So far, the overall data indicate that genomic co-localization
of GR and PPAR underlies a cooperative transcriptional
response that shifts the primary hepatocyte metabolism to-
ward increased lipid utilization.
To find out whether and how the gene-regulatory events
upon combined ligand treatment translated into changes at
the FA metabolite levels, we performed a metabolomics ex-
periment using primary hepatocytes stimulated with Dex,
GW and their combination using the same conditions and
stimulation time (19 h) as in the RNA-seq experiment. The
pattern of ligand response among significantly perturbed
FAs was uniform and with the exception of myristate, Dex
treatment increased the quantity of all other FAs. Strikingly,
this increase was almost completely reversed upon com-
bined stimulation with Dex and GW (Figure 4A and B).
Hence, the combination of Dex and GWmodulates the ac-
tivity of the key controlling genes/enzymes in such a way
that the FA content of the hepatocyte is normalized back
to control levels.
Transcriptional antagonism can switch to cooperativity when
hepatocyte cells move from fed to fasting states in culture
The cooperative response and its dependency on the pres-
ence of PPAR (19 h stimulation) were confirmed for a
panel of selected target genes (Figure 5A). To find out
whether all of the co-controlled target genes responded to
ligand with a similar kinetics, we recapitulated the exper-
iment including shorter incubation times (2 h, 4 h, 6 h).
To our surprise, for a subset of re-tested genes the direc-
tion of this regulation showed an intriguing dependency
on the stimulation time (Figure 5B). Specifically, upon a
short stimulation (2 h) we observed an antagonistic effect
of adding Dex with respect to the GW-only induction for
Pdk4, Ehhadh and Angptl4 – genes cooperatively activated
upon longer treatment (Figure 5B, black versus light grey
bars, compare DexGW versus GW, marked with red ver-
sus blue arrows for Pdk4 and Eci2 as opposite examples).
In line herewith, for the same genes, the antagonism is also
observed assessing pPol2-Ser2 enrichment as a marker for
transcriptional activity, upon 1 h stimulation (Supplemen-
tary Figure S6). This initial antagonism was completely lost
when including an additional starvation step to lose poten-
tial confounding endogenous factors, by incubating isolated
hepatocytes in serum-freeWilliam’s medium for an extra 24
h prior to stimulation. Interestingly, the overall magnitude
of the cooperative response was also enhanced in this set-
ting (Figure 5C).
Given those results and the fact that mice used for hep-
atocyte isolation were not fasted, we hypothesized that the
antagonistic effect at shorter ligand induction times may re-
sult from a prior exposure of cells to high glucose and in-
sulin, concomitant with a fed state. To test how a change in
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Figure 3. Gene expression profiling in primary hepatocytes stimulated with GR- and PPAR-agonists. (A) Heatmap shows the relative expression of the
cooperatively induced genes. Color scale represents fragments per kilobase per million values scaled across treatments (z-score). (B) Enrichment of the GO-
terms for the cooperatively induced genes, 20 most significant terms are shown in the table (see also Supplementary Figures S4 and S5). (C) Enrichment
of ChIP-seq peaks near Transcription Start Sites (TSS) of the co-regulated genes – the fraction of genes with a GR, PPAR or co-bound peak at a given
distance from the TSS as compared to a random set of genes is shown. NI, non-induced (solvent only).
nutritional conditions affects the response to Dex and GW,
we set up a model to mimic fed-to-fast and fast-to-fed tran-
sitions in primary hepatocyte cultures. We used a high glu-
cose (11 mM) medium supplemented with insulin (100 nM)
as a surrogate for the fed state and a low glucose (1 mM)
medium supplemented with pyruvate (1 mM), glutamine
(2 mM) and forskolin (10 M) to simulate a fasting state
(see Materials and Methods for details). Isolated cells were
first pre-incubated in serum-free William’s medium for 24 h
(as in Figure 5C) to eliminate the influence of endogenous
factors. Cells were next put for 3 h in either ‘fed’ or ‘fast’
medium and stimulated with ligands after alternating the
media from ‘fed’ to ‘fast’ or ‘fast’ to ‘fed’. We could clearly
reproduce the regulation-switch in the fed-to-fast condition
for Pdk4 as one of the prototypical genes for which GW-
mediated induction was strongly antagonized by Dex after
2 h and cooperatively induced after 6 h (Supplementary Fig-
ure S7). However, prolonged hepatocyte culturing resulted
in a diminished response to GW in case of Angptl4 and
Ehhadh, which prevented us from recapitulating early an-
tagonism for those two genes. Nevertheless, a clear suppres-
sion of the cooperative response in fast-to-fed as compared
to the fed-to-fast condition was apparent, suggesting sensi-
tivity of the response to a nutritional context. Among the
tested genes, this suppression was especially clear for Cpt1a
and Hmgcs2, which are rate-limiting enzymes for FA oxi-
dation and ketogenesis, respectively (Supplementary Figure
S7A). In line with our previous findings, initial antagonism
was not observed for Eci2, Plin5 and Agpat3, confirming
that this type of regulation is restricted to a subset of lipid
metabolism-controlling genes. For all of the genes, how-
ever, a pronounced cooperativity is consistently observed
upon combining GW and Dex in a fasting state. Because of
the time-dependency of the cooperative effect, we wondered
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Figure 4. The effect of Dex and GW on the hepatic fatty acid content
(metabolomics). (A) Heatmap showing regulation of significantly per-
turbed fatty acids in the metabolomics experiment. (B) Boxplot compar-
ing the global ligand effects on all significantly perturbed fatty acids (black
dots indicate outliers). The ‘**’ denotes a P-value < 0.01 as assessed us-
ing Welch’s t-test with a Bonferroni correction. NI, non-induced (solvent
only).
whether novel protein production might facilitate and pre-
cede the fasting response. Indeed, inclusion of the protein
synthesis inhibitor cycloheximide in the fed-to-fast set-up
eradicated cooperative gene inductions at 6 h, of two exem-
plary target genes Eci2 and Pdk4 (Supplementary Figure
S7B).
Transcriptional cooperativity of GR and PPAR co-
controlled lipid metabolism genes coincides with a strong re-
cruitment of phosphorylated AMPK to the promoter complex
Given the suppression of cooperativity upon entry into the
fed state, we speculated that the nutrient sensing kinase
AMPK, which is known to be inhibited by high insulin
and glucose levels (41,42) could be involved in the coop-
erative cross-talk between GR and PPAR. In support, we
observed a complete suppression of the response toDex and
GW and no cooperativity in the fed-to-fast condition when
cells were co-treated with the pharmacological AMPK in-
hibitor dorsomorphin (Figure 6A), also known as Com-
poundC.As a control, we verified that this pharmacological
compound did not generally inhibit gene transcription by
comparing total mRNA levels and by assessing mRNA lev-
els of GAPDH, SCD1 andHsp70 (data not shown). To test
whether AMPK is directly involved in the GR and PPAR-
mediated transcriptional regulation we performed a ChIP-
qPCR experiment in the fed-to-fast condition upon 1 and
5 h stimulation with Dex and GW. In parallel with the pro-
moter recruitment of phospho-Thr172 AMPK (pAMPK)
we monitored pPol2-Ser2 as a marker of a transcriptional
activity. Shortly after the entry into the fast state (1 h stim-
ulation) we did not detect any major changes in pAMPK
recruitment and pPol2-Ser2 showed only a small increase
for Eci2, while for Pdk4 there was a decrease upon co-
stimulation as compared to GW alone, which is in line
with the previously observed strong early antagonistic re-
sponse for this gene. However, pAMPK was recruited af-
ter 5 h in a cooperative manner upon co-stimulation and
its appearance also coincided with a cooperative increase
in pPol2-Ser2 signal (Figure 6B). Using the mammalian
two-hybrid assay, termed MAPPIT (27,43) (Figure 6C) we
also identified a statistically significant interaction between
two regulatory subunits of AMPK (PRKAG2/AMPK-2
and PRKAG3/AMPK-3) and full length PPAR but not
full length GR (Figure 6C). GST-pull down analysis us-
ing GST-PPAR combined with a recombinant LKB1-
activated pAMPK (121) heterotrimeric complex (44),
and in vitro transcribed and translated GR in reticulo-
cyte lysates shows that, at least in vitro, a signal for GR
can be detected when PPAR is pulled down along with re-
combinant active pAMPK (Figure 6D and Supplementary
Figure S8) suggesting a physical complex harboring these
three proteins is possible. The interaction data suggest that
a contact interface involving PPAR and the  -subunits of
AMPKmay support promoter recruitment of the pAMPK
complex, in a constellation that may additionally accom-
modate GR. Overall, the data add up to a model whereby
recruitment of pAMPK to GR and PPAR co-controlled
genes in response to a combined agonist treatment is re-
quired for their full transcriptional activity.
Catabolic fasting in mice correlates with an increased recruit-
ment of phosphorylated AMPK at the Pdk4 enhancer
To validate the in vitro observations in vivo, mice were sub-
ject to a prolonged fasting of 16 h and either allowed to
stay on this regimen (‘fast-fast’) or allowed to refeed (‘fast-
refed’) for 30 min before sacrifice. Glucose levels in the fast-
ing states ranged between 100–150 mg/dl whereas those
in the refed state ranged between 150–200 mg/dl, indicat-
ing a normal response to refeeding (data not shown). Us-
ing ChIP-qPCR, we confirmed that pAMPK is robustly re-
cruited to the Pdk4 enhancer under the fast-fast condition
and that this enrichment undergoes suppression in case of
a short refeeding (Figure 7A). Similar findings were made
for Ehhadh (data not shown). As a control and as expected,
we observed a global decrease in AMPK phosphorylation
upon refeeding without a change in the total AMPK ex-
pression levels (Figure 7B, left panel). Together, these data
confirm that the chromatin recruitment of pAMPK in liver
is responsive to fast/refeeding signals. In line with a role
for GR Ser211 phosphorylation when GR is transcription-
ally active (45), overall pSer211GR levels were higher in the
‘fast-fast’ state as compared to the ‘fast-refed’ state (Figure
7B, right panel). Finally, to investigate whether the observed
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Figure 5. qPCR analysis of the selected cooperatively induced genes (primary murine hepatocytes). (A) Comparison of WT and PPAR-KO cells upon
stimulation in Wiliams medium for 19 h. Ligands were introduced 2h after isolation (as in the RNA-seq). (B and C) Time kinetics of the response; (B)
ligands (1 MDex, 0.5 MGW) were introduced 2 h after hepatocyte isolation or (C) after 24 h serum-starvation. Fold induction upon combined ligand
stimulation was compared with single ligand treatments using one-way ANOVA and Dunnett’s test (*, ** and *** denote P-values < 0.05, 0.01 and 0.001,
respectively, n = 3 (panels A and C) or 2 (panel B)) (see also Supplementary Figure S5).
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Figure 6. The involvement of AMPK in the response to GR-/PPAR-ligands. Hepatocytes were serum-starved for 24 h after isolation, incubated for 3 h in
the medium mimicking fed state and stimulated with ligands (1 MDex, 0.5 MGW) after switching to the fasting medium for the indicated time points.
(A) The effect of ligands on gene expression (qPCR) in the presence/absence of dorsomorphin (10 M). (B) Promoter recruitment of phospho-Thr172
AMPKand phospho-Ser2 Pol2 in response to ligand treatment (ChIP-qPCR). Fold induction (qPCR) or relative enrichment (ChIP-qPCR) upon combined
stimulation was compared with single ligand treatments using one-way ANOVA and Dunnett’s test (*, ** and *** denote P-values < 0.05, 0.01 and 0.001,
respectively, n= 2 (panel A) or 3 (panel B)). (C) Left panel. The scheme illustrates the concept of theMAPPIT technology (reprinted with permission from
(27). Copyright 2009 American Chemical Society). In short, full length bait protein is fused to a signaling-deficient cytokine receptor (Y to Fmutations), in
this case the leptine receptor and the prey protein is fused to gp130 domain containing JAK2 phosphorylation sites. Upon bait-prey interaction the gp130
domain is phosphorylated by JAK2 in response to cytokine receptor stimulation, allowing the recruitment of STAT3 to phosphorylated gp130 sites and
subsequent phosphorylation and activation of STAT3. Activated STAT3 translocates to the nucleus and induces the expression of the STAT3-responsive
reporter. The induction of the STAT3-reporter in response to a cytokine is used as a proxy of the bait-prey interaction strength (for detailed explanation
see (27)). Right panel. Interaction between full length PPAR/GR-bait, activated by their respective ligands Dex (1 M) and GW (0.5 M) and full length
AMPK subunits. * and ** indicate P-values < 0.05 and < 0.01 as assessed with the Welch’s t-test and Holm P-value correction, n = 3. (D) GST-pull
down experiment demonstrating interaction between GST-PPAR with in vitro transcribed/translated GR and recombinant activated AMPK complex
(121) in the presence of Dex and GW7647. Of note, the strong signal for pAMPK associating with GST-PPAR in lane 2 is caused by the fact that
this positive control set-up was performed in the absence of rabbit reticulocyte lysate in the binding mix. ns: non-specific band. GST-ctrl: GST fused to a
5HT7 serotonin receptor domain was used as a negative control.
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Figure 7. Catabolic fasting in mice correlates with an increased recruitment of phosphorylated AMPK at the Pdk4 enhancer (A) Mice (5 mice/group) were
subject to overnight fasting, and subsequently allowed to a refeeding step for 30 min or kept at a fasting state. After the sacrifice, livers were collected,
snap-frozen and used for ChIP-qPCR or for WB. ChIP-qPCR with anti-pAMPK antibody or IgG: The enrichment data are presented relative to input
chromatin and represents the mean value from 5mice± SE. The statistical significance was assessed using a two-tailed t-test and ‘*’ denotesP-value< 0.05.
(B) Western analysis result of one group of the experiment in (A) probed for liver AMPK and pAMPK (left panel) and of liver GR and phospho-Ser211
GR (right panel) in fast-refed and fast-fast samples, using actin as a loading control. (C)Mice (5 mice/group) were subject to 3 h or 16 h fasting, followed by
i.p. injection with either solvent or with Dex (2 mg/kg) and GW (2 mg/kg) for 4 h. After sacrifice, livers were collected, snap-frozen and further processed
for mRNA analysis via qPCR. Household genes were selected via GENORM (qBase software package) and relative expression levels were calculated.
Data were analyzed for statistical significance using a non-parametric Wilcoxon rank sum test; * and ** denote P-values < 0.05 and < 0.01, respectively.
cooperative responses at the gene expression level can be
pushed further when exogenously administering synthetic
GR and PPAR ligands over a background of (catabolic)
fasting, we compared groups of mice fasted for either 3 h
or 16 h, after which Dex (2 mg/kg) and GW (2 mg/kg) was
given i.p. for 4 h. qPCR results show that mRNA levels of
Pdk4 and Ehhadh are enhanced comparing 3 h versus 16 h
fasting (Figure 7C). Administering a combination of Dex
and GW to mice increases liver mRNA levels of these, and
other, PPAR/GR controlled genes even further (Figure 7C
and Supplementary Figure S9).
DISCUSSION
Nuclear receptor cross-talk is a fairly novel research area
with potential therapeutic implications, as the behavior of
two drug targets co-triggered may yield a different biologi-
cal outcome compared to the single treatments. Cross-talk
mechanisms offer an advantage to the organism, especially
when exceptional conditions require a flexible adaptation of
a particular gene repertoire. We report here on a novel nu-
clear receptor cross-talk mechanism in primary hepatocytes
and in murine liver in vivo, emerging only under the specific
condition of a prolonged starvation and aimed at key con-
trolling genes of glucose and lipidmetabolism.More specifi-
cally, we identified pAMPK as a new component associated
with lipid metabolic gene promoters, recruited in response
to both combined GR and PPAR activation specifically
under culturing conditionsmimicking starvation (Figure 6).
This findingwas recapitulated upon prolonged starvation in
animals, relying on an endogenous activation of these nu-
clear receptors, which is expected following nutrient depri-
vation stress (Figure 7).
Previous studies observed that FAs or synthetic PPAR-
ligands combined with GCs can synergistically induce
Ehhadh, Acox1 and peroxisomal thiolase expression in pri-
mary hepatocytes, hepatoma cells or rat liver in vivo (46–
48) yet the underlying mechanism remained unclear. Up-
regulation of PPAR by ligand-activated GRwas proposed
to explain this synergy and PPAR expressionwas shown to
follow endogenous corticosterone levels in rats (49). While
our own results in hepatocytes do support the up-regulation
of PPAR by GCs (data not shown), this mechanism ap-
pears only part of the observed cross-talk. Indeed, by map-
ping GR and PPAR cistromes in primary hepatocytes, ge-
nomic binding sites of GR overlap more than half of the
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PPAR cistrome (Figure 1). The functional significance of
binding site co-localization is further supported by a strong
enrichment of co-occupied regions in the vicinity of cooper-
atively co-regulated genes (Figure 3), supporting a role for a
direct transcriptional regulation.Mechanistically, we found
that the dependency of GR to co-localize with PPAR at
PPRE genes occurs in a target gene-specific manner (Fig-
ure 2 and Supplementary Figure S2).
The regulation of the Pdk4 gene (Figure 2), coding for
an important control enzyme determining the fate of pyru-
vate, may either be consistent with a tethering recruitment
model or else, may be explained by a role for PPAR as a
chromatin-priming pioneering factor, as has been proposed
for other transcription factors (50,51). Our data suggest
that ligand-activated PPAR may facilitate or support GR
recruitment to co-bound sites yet the presence of PPAR
is clearly not an absolute pre-requisite for GR occupancy
at other regulatory sites, e.g. as found for Angptl4 (Figure
2). Nevertheless, the transcriptional activity of GR does de-
pend on the presence of PPAR as Dex induction of co-
regulated lipid metabolic genes was consistently reduced in
PPAR-KO hepatocytes (Figure 5). The time-dependency
of the cooperative gene induction (Figure 5) which is reca-
pitulated following a fed-to-fast transition over longer times
(Supplementary Figure S7A) correlates with a need for
novel protein synthesis (Supplementary Figure S7B). This
observation could theoretically be reconciled with a GC-
induced increase of PPAR (49), as we found to be the case
in hepatocytes (data not shown) or of levels of AMPK (52),
or both. Surprisingly, we did not find mRNA upregulation
of any of these genes in the liver samples following treatment
of mice with Dex and GW after a prolonged fasting state
(Supplementary Figure S10); a situation for which cooper-
ativity on GR/PPAR co-controlled genes was apparent as
depicted in Figure 7C. Fromour data, increased levels of yet
another regulatory protein, possibly along with sustained
proper modifications, i.e. phosphorylation of AMPK and
GR, may act in concert to build a protein complex able to
mount a powerful fasting response at gene regulatory sites.
To explore additional levels of the cross-talk, we stud-
ied hepatocyte metabolite behavior following combined
GR/PPAR activation. The results of the metabolomics
experiment in primary hepatocytes showed that Dex treat-
ment leads to the accumulation of intracellular FAs (Figure
4), in line with previous studies (Jia et al., 2009) (53). Inter-
estingly, the combined stimulation with a PPAR-agonist
counteracted the lipogenic action of Dex and reversed FA
levels back to the control condition. This result demon-
strates that the intra-hepatic cross-talk between GR and
PPAR exists also at the metabolite level, with the cooper-
ative transcriptional response as a likely contributor to the
observed reduction in FA levels.
The key mechanism of enzyme control behind the switch
from FA oxidation to glucose utilization and lipogene-
sis upon fast-to-fed involves insulin-induced acetyl-CoA-
carboxylase (ACC) activity (54). ACC catalyzes the first
step of FA synthesis and produces malonyl–CoA, which
acts as a potent allosteric inhibitor of Cpt1a, thus limit-
ing mitochondrial FA import and oxidation (54–56). This
process is reversed by AMPK during fasting, via AMPK-
mediated phosphorylation and potent inhibition of ACC
activity (57–59). While ACC inhibition by AMPK is a well-
recognized mechanism, several studies indicate the impor-
tance of nuclear AMPK and its effects on gene expression.
Indeed, AMPK was shown to phosphorylate and control
the activity of several metabolic cofactors and transcription
factors, including PGC1 (60), Med1 (61), CREB (62) and
Foxo3 (63). The presence of both AMPK1 and AMPK2
subunits has been detected in the nucleus and was shown
to be dynamically regulated (64–66) yet chromatin associa-
tions were thus far never reported. In line with our findings,
nuclear translocation of the liver AMPK1 catalytic sub-
unit has been reported to follow circadian rhythms in vivo
and to respond to low glucose conditions (66).
PPAR-ligands have also been demonstrated to increase
both the phosphorylation and activity of AMPK (67,68).
Although a direct interaction between PPAR and AMPK
was observed before (69), the influence of AMPK activa-
tion on PPAR activity is still not completely clear. AMPK
was shown to co-activate PPAR in an inactive ATP-bound
state (69,70) but the effects of pharmacological AMPKacti-
vation on PPAR activity are contradictory, showing both
inhibition (69,70) and activation (71). Similarly, GCs can
activate liver AMPK (52) and pharmacological AMPK ac-
tivation was shown to alter the effects of glucocorticoids on
liver carbohydrate metabolism (13), however, via an indi-
rect mechanism, involving p38 MAPK activation. In sup-
port of the findings of Nader et al., we observe in murine
liver, under conditions in which AMPK is expected to be
active, i.e. prolonged fasting, that this indeed coincides with
phosphorylation of GR at Ser211. We go on to show that
refeeding dampens these modifications (Figure 7). Given
the observation that PPAR, GR and pAMPK can form
a trimeric complex in vitro (Figure 6), we postulate that
AMPKmay influence single GR or PPAR signaling path-
ways in a different manner as compared to a coordinately
regulated cross-talk upon simultaneous co-signaling of GR
and PPAR. Only the latter event seems to involve a direct
chromatin recruitment of AMPK. Indeed, in line with our
finding that phosphorylated AMPK is primarily retrieved
at the promoters of GR/PPAR co-controlled genes, we
show that AMPK inhibition is a strong cue to short circuit
GC and PPAR agonist co-controlled cooperative gene ex-
pression of lipid catabolic genes (Figure 6). Importantly, the
promoter recruitment of pAMPK was strongly enhanced
upon combined activation of both nuclear receptors and
this occurred only 5 h after cells underwent transition from
a high-insulin, high glucose (fed) condition to a fasting
state (Figure 6). This delayed recruitment of pAMPK was
accompanied by an increase in transcriptional activity as
measured by pPol2-Ser2 enrichment and associated with
a regulatory switch from Dex-mediated repression to co-
activation of Pdk4 (Figure 6). An interaction between reg-
ulatory subunits of AMPK and PPAR but not GR, indi-
cates that PPARmay be more likely to function as a direct
physical contact point involved in the genomic pAMPK re-
cruitment (Figure 6). Nevertheless, a GST-pull down exper-
iment demonstrates that GR can additionally associate, in
support of the existence of a trimeric complex between these
three proteins, albeit under in vitro conditions (Figure 6 and
Supplementary Figure S8).
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Figure 8. Chromatin recruitment of activated AMP kinase drives fasting response genes co-controlled by GR and PPAR. The model depicts concluding
findings on transcriptional mechanisms, specifically for the subset of GC and PPAR agonist co-controlled lipid-oxidative-genes that are subject to changes
of the nutritional state and that demonstrate pAMPK recruitment upon longterm fasting. Under this particular condition, our data are further consistent
with an involvement of GR, phosphorylated at Ser211. The top row shows the transcriptional activity of genes only triggered by GW7647 (GW alone)
whereas the bottom row shows transcriptional activity of genes triggered by GW7647 and Dex. A and B refer to the underlying mechanisms that were
identified, with Ehhadh andAngptl4 exemplifying genes for which independent transcription (A) factor binding was found and Pdk4 being the prototypical
example of a (B) tethering binding. Note that actually also a third subset of co-controlled genes was identified, i.e. lipid metabolism genes that are not
subject to a nutritional switching mechanism but move from low to high cooperativity when progressing to catabolic fasting (not depicted here). FAO –
Fatty Acid Oxidation.
In summary, we show that GR and PPAR cooperatively
activate a lipid catabolic gene program in primary hepa-
tocytes via a novel mechanism involving direct promoter
recruitment of activated AMPK and we present a possi-
ble model in Figure 8 on how our combined data could
be interpreted. Although we could show formation of a
trimeric complex in vitro, we bid for caution when trans-
lating to the in vivo situation, as a limitation of our data
is that we were unable, due to technical reasons, to unam-
biguously prove via re-ChIP that these proteins are also
able to directly form a trimeric complex in vivo at the pro-
moter level. Given the dependency of the transcriptional
response to Dex and GW on AMPK activity/recruitment,
an attenuated ligand response in fed as compared to fasted
conditions and a recapitulation of a stronger AMPK chro-
matin recruitment in fasted as compared to refedmice along
with confirmatory results in vivo that Dex/GW coopera-
tively triggers glucose/lipid metabolism genes in fasted liver
(Figure 7), the observed cooperativity is likely most relevant
for an adaptation of intra-hepatic metabolism to states of
prolonged fasting, under which FAs serve as the main en-
ergy source.
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